Prime Medicine (PRME) Consolidated Net Income: 2021-2025

Historic Consolidated Net Income for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to -$52.8 million.

  • Prime Medicine's Consolidated Net Income fell 0.60% to -$52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$199.6 million, marking a year-over-year increase of 8.97%. This contributed to the annual value of -$195.9 million for FY2024, which is 1.14% up from last year.
  • Latest data reveals that Prime Medicine reported Consolidated Net Income of -$52.8 million as of Q3 2025, which was down 0.46% from -$52.6 million recorded in Q2 2025.
  • Prime Medicine's 5-year Consolidated Net Income high stood at -$16.4 million for Q3 2021, and its period low was -$65.6 million during Q4 2023.
  • Over the past 3 years, Prime Medicine's median Consolidated Net Income value was -$51.9 million (recorded in 2025), while the average stood at -$50.1 million.
  • Data for Prime Medicine's Consolidated Net Income shows a peak YoY increase of 37.54% (in 2022) and a maximum YoY decrease of 78.83% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Prime Medicine's Consolidated Net Income stood at -$62.9 million in 2021, then surged by 37.54% to -$39.3 million in 2022, then slumped by 67.10% to -$65.6 million in 2023, then spiked by 35.60% to -$42.3 million in 2024, then decreased by 0.60% to -$52.8 million in 2025.
  • Its Consolidated Net Income stands at -$52.8 million for Q3 2025, versus -$52.6 million for Q2 2025 and -$51.9 million for Q1 2025.